These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17414063)

  • 1. Acute tubulointerstitial nephritis associated with long-term gemcitabine therapy.
    Yamamoto A; Naruse S; Ito M; Ishiguro H; Ko SB; Yoshikawa T; Kondo T; Goto H
    Pancreas; 2007 Apr; 34(3):378-9. PubMed ID: 17414063
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine.
    De Smet D; Jochmans K; Neyns B
    Ann Hematol; 2008 Jun; 87(6):495-6. PubMed ID: 18097666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer].
    Dahan L; Ressiot E; Cournede A; Ries P; Duluc M; Laquiere A; Laugier R; Braguer D; Seitz JF
    Gastroenterol Clin Biol; 2007 Dec; 31(12):1143-5. PubMed ID: 18176375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma.
    Choi M; Woywodt A; Göbel U; Schneider W; Kettritz R
    Nephrol Dial Transplant; 1999 Oct; 14(10):2523-4. PubMed ID: 10528696
    [No Abstract]   [Full Text] [Related]  

  • 5. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
    Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
    Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
    [No Abstract]   [Full Text] [Related]  

  • 6. Gemcitabine and haemolytic-uraemic syndrome.
    Ruiz I; Del Valle J; Gómez A
    Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
    [No Abstract]   [Full Text] [Related]  

  • 7. First case report associating gemcitabine with hypersensitivity reaction in a patient with pancreatic cancer.
    Saif MW; Chakerian P; Kaley K; Lamb L
    JOP; 2010 May; 11(3):273-4. PubMed ID: 20442527
    [No Abstract]   [Full Text] [Related]  

  • 8. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
    Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
    Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction following gemcitabine therapy--a case report.
    Kalapura T; Krishnamurthy M; Reddy CV
    Angiology; 1999 Dec; 50(12):1021-5. PubMed ID: 10609769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anal pruritus after cancer chemotherapy with gemcitabine.
    Hejna M; Valencak J; Raderer M
    N Engl J Med; 1999 Feb; 340(8):655-6. PubMed ID: 10049089
    [No Abstract]   [Full Text] [Related]  

  • 11. Gemcitabine for pancreatic cancer: how hard to look for clinical benefit? An American perspective.
    Gelber RD
    Ann Oncol; 1996 Apr; 7(4):335-7. PubMed ID: 8805922
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe acute lung injury induced by gemcitabine.
    Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
    Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.
    Baron D; Mayo A; Kluger Y
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):90-1. PubMed ID: 16477934
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe ischemic myopathy localized in an irradiated area following gemcitabine therapy].
    Pariente A; Berthelémy P; Arotçarena R; Bénichou M; Calès V; Dujols JP
    Presse Med; 2000 Oct; 29(30):1650. PubMed ID: 11089501
    [No Abstract]   [Full Text] [Related]  

  • 15. Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.
    Spanos S; Vourliotaki I; Drossitis I; Tsoussis S
    J BUON; 2009; 14(4):728-9. PubMed ID: 20148474
    [No Abstract]   [Full Text] [Related]  

  • 16. Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
    Saadati H; Peccerillo J; Kaley K; Schilsky ML; Saif MW
    JOP; 2009 Sep; 10(5):573-5. PubMed ID: 19734642
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of pancreatic cancer complicated by gemcitabine-induced peripheral edema].
    Shitara K; Ishiguro A; Munakata M; Sakata Y; Hirata N; Yabu K; Wada R
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1981-4. PubMed ID: 16282740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine-induced pulmonary toxicity in a patient with pancreatic cancer.
    Hiraya D; Kagohashi K; Sakamoto N; Kondo T; Satoh H
    JOP; 2010 Mar; 11(2):186-8. PubMed ID: 20208333
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
    Vega J; Parodi C; Méndez GP; Goecke H
    Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine associated pseudocellulitis.
    Singh A; Hampole H
    J Gen Intern Med; 2012 Dec; 27(12):1721. PubMed ID: 22696254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.